Search - tctmd.com

Displaying 61 - 80 of 334

Sort: Relevancy | Date

News Conference News ACC 2023

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

Todd Neale

March 05, 2023

News Conference News ACC 2023

On-site Machine Learning-Based FFRCT Feasible, Informative: TARGET

Caitlin E. Cox

March 04, 2023

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Shelley Wood

March 04, 2023

News Conference News ACC 2023

STOP-CA: Atorvastatin Curbs Heart Function Decline During Chemotherapy

L.A. McKeown

March 04, 2023

News Conference News ACC 2023

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Michael O'Riordan

March 04, 2023

News Conference News ACC 2023

By Mid-Century, More Hot Days Will Spur More CV Deaths

Caitlin E. Cox

March 02, 2023

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Conference News ACC 2022

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Michael O'Riordan

April 13, 2022

News Conference News ACC 2022

Managing AF Patients Undergoing PCI—Some Lingering Questions

Michael O'Riordan

April 12, 2022

News Conference News ACC 2022

Global STEMI Outcomes May Improve With Tracking, GHATI Hints

Shelley Wood

April 11, 2022

News Conference News ACC 2022

BIO|GUARD-MI: Post-MI Arrhythmia Monitoring Falls Short

Todd Neale

April 11, 2022

News Conference News ACC 2022

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

Michael O'Riordan

April 07, 2022

News Conference News ACC 2022

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

Michael O'Riordan

April 06, 2022

Presentation ACC 2022

The Clinical Effect Of Arrhythmia Monitoring After Myocardial Infarction

Presenter: Christian Jons

April 04, 2022

Presentation ACC 2022

A Randomized Trial To Confirm The Safety And Effectiveness Of Chocolate Touch Paclitaxel Coated PTA Balloon Catheter In Above The Knee Lesions

Presenter: Alexandra Lansky

April 04, 2022

Presentation ACC 2022

Comparison Of Fractional Flow Reserve-guided And Intravascular Ultrasound-guided Percutaneous Coronary Intervention In Intermediate Coronary Artery Stenosis: The FLAVOUR Randomized Clinical Trial

Presenter: Bon-Kwon Koo

April 04, 2022

Presentation ACC 2022

The PACMAN AMI Randomized Clinical Trial

Presenter: Lorenz Räber

April 04, 2022

Presentation ACC 2022

A Single Ascending Dose Study of an siRNA Targeting Lipoprotein(a)

Presenter: Steven E. Nissen

April 04, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

News Conference News ACC 2022

In Vaccine Era, Deaths Drop Sharply in STEMI Patients With COVID-19

Caitlin E. Cox

April 04, 2022

Advertisement

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

On-site Machine Learning-Based FFRCT Feasible, Informative: TARGET

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

STOP-CA: Atorvastatin Curbs Heart Function Decline During Chemotherapy

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

By Mid-Century, More Hot Days Will Spur More CV Deaths

What’s Going to Be Hot at ACC/WCC 2023?

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Managing AF Patients Undergoing PCI—Some Lingering Questions

Global STEMI Outcomes May Improve With Tracking, GHATI Hints

BIO|GUARD-MI: Post-MI Arrhythmia Monitoring Falls Short

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

The Clinical Effect Of Arrhythmia Monitoring After Myocardial Infarction

A Randomized Trial To Confirm The Safety And Effectiveness Of Chocolate Touch Paclitaxel Coated PTA Balloon Catheter In Above The Knee Lesions

Comparison Of Fractional Flow Reserve-guided And Intravascular Ultrasound-guided Percutaneous Coronary Intervention In Intermediate Coronary Artery Stenosis: The FLAVOUR Randomized Clinical Trial

The PACMAN AMI Randomized Clinical Trial

A Single Ascending Dose Study of an siRNA Targeting Lipoprotein(a)

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

In Vaccine Era, Deaths Drop Sharply in STEMI Patients With COVID-19

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content